Asymptomatic superior vena caval occlusion: A complication of nonthoracotomy implantation of cardioverter defibrillator

PACE - Pacing and Clinical Electrophysiology

Volumn 21, Issue 8, 1998, Pages 1676-1678

  Minen, Giorgio ^a   Proclemer, Alessandro ^a   Facchin, Domenico ^a  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Implantable cardioverter defibrillator; Superior vena caval syndrome

Indexed keywords

ANTICOAGULANT AGENT;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; AZYGOS VEIN; CARDIOVERSION; CASE REPORT; COLLATERAL CIRCULATION; DEFIBRILLATOR; DEVICE; HEART DILATATION; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE FIBRILLATION; HUMAN; IMPLANTATION; ISCHEMIC HEART DISEASE; MALE; PULSE GENERATOR; SUPERIOR CAVA VEIN OBSTRUCTION;

ADULT; ANGIOGRAPHY, DIGITAL SUBTRACTION; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; MALE; SUPERIOR VENA CAVA SYNDROME;

EID: 0031877750     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1998.tb00260.x     Document Type: Article

References (5)

1. Lawton JS, Wood MA, Gilligan DM, et al. Implantable transvenous cardioverter defibrillator leads: The dark side. PACE 1996; 19:1273-1278.
2. Block M, Hammel D, Isbruch F, et al. Results and realistic expectations with transvenous load systems. PACE 1992; 15(3):665-670.
3. Schwartzman D, Nallamothu N, Callans D, et al. Postoperative lead-related complications in patients with nonthoracotomy defibrillation lead systems. J Am Coll Cardiol 1995; 26:776-786.
4. Nunain SO, Roelke M, Trouton T, et al. Limitations and late complications of a third-generation automatic cardioverter-defibrillators. Circulation 1995; 91:2204-2213.
5. Mazzetti H, Dussaut A, Tentori C, et al. Superior vena cava occlusion and/or syndrome related to pacemaker leads. Am Heart J 1993; 125:831-837.